The journey to a diagnosis for rare neuromuscular diseases (NMDs) is often a long and difficult one. Patients frequently navigate a complex "diagnostic journey" that can stretch over years, involving a myriad of tests—from MRIs and biopsies to genetic screening—often scattered across different departments and timeframes. In December, the fourth CoMPaSS-NMD webinar introduced a [...]
This week marks a major milestone in the evolution of the CoMPaSS-NMD project. On Thursday, April 16th, and Friday, April 17th, our consortium will host two critical workshops to present the ATLAS Platform to our international Scientific Advisory Board (SAB) for its first external expert evaluation. Until now, the ATLAS has undergone rigorous internal [...]
The CoMPaSS-NMD project is reaching a major milestone in its Young Investigator Training (YIT) initiative. On April 21, 2026, we will host our fifth and final webinar: "The CoMPaSS-NMD ATLAS: A New Tool for Clinicians and Researchers." Neuromuscular diseases (NMDs) are often rare and heterogeneous, with similar phenotypes hiding different underlying mechanisms. The CoMPaSS-NMD [...]
On March 3, 2026, the CoMPaSS-NMD project hosted a landmark event at TECNALIA Research & Innovation in Donostia-San Sebastián, also accessible globally via a live stream. The event, "Ethics and Regulation in AI for Health," arrived at a critical juncture as the European healthcare sector navigates the implementation of the EU AI Act and [...]
For many living with rare diseases, the "diagnostic odyssey" is a gruelling reality—a path often marked by years of uncertainty, misdiagnoses, and emotional strain. On 12 February 2026, the CoMPaSS-NMD project will take a significant step towards shortening this journey as we host a major press conference at the Sala Stampa of the Chamber [...]
In Modena, an event brought together individuals affected by neuromuscular conditions to explore the potential of artificial intelligence in achieving more precise diagnoses and offering hope for future advancements. On Saturday, 10th May, Modena hosted an event entitled “Precision Diagnosis and Artificial Intelligence for Neuromuscular Patients: New Tools and New Possibilities”, dedicated to patients, [...]
The challenge of diagnosing rare muscle diseases Imagine visiting a doctor for unexplained difficulty of walking only to be told that, despite advanced genetic testing, the cause remains unknown. This is the reality for many patients with rare neuromuscular diseases (NMDs) - a group of conditions affecting the muscles and nerves. Scientists have linked [...]
Join us for this seminar as we delve into the complex and fascinating world of muscle behavior, exploring both normal function and the changes that occur in neuromuscular diseases. Who should attend? The workshop is primarily aimed at healthcare professionals and researchers in NMD but is open to anyone interested. DATE: 11 March 2025 [...]
The CoMPaSS-NMD consortium met in person for the second time after the kick-off meeting in June 2023, hosted by Ludwig-Maximilians-Universität München, in a beautiful historic location, the Carl Friedrich von Siemens Foundation, established in 1958 on the initiative of entrepreneur Ernst von Siemens. It bears the name of his father Carl Friedrich von Siemens, who [...]
Artificial Intelligence supports healthcare professionals and patients on their path to curing diseases and improving health. The interpretation of complex scenarios is facilitated by artificial intelligence platforms that share knowledge, shedding light on rare or little-known diseases, while preserving patient privacy. Knowledge derived from data helps doctors make decisions to treat patients and ensure a better [...]